Long-term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,1,6 Mth Schedule in Healthy Adults
Clinical trial NCT00289770 · COMPLETED
Trial details
- NCT number
- NCT00289770
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-11-01
- Primary completion
- 2004-12-20
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.